Trial Profile
A clinical study of OvcaVax for ovarian cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2017
Price :
$35
*
At a glance
- Drugs 4T1 IL-2 GM CSF vaccine (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- 20 Oct 2017 New trial record